Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation
- PMID: 11583570
- PMCID: PMC1222142
- DOI: 10.1042/0264-6021:3590249
Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation
Abstract
The N-linked glycans on transferrin and alpha(1)-antitrypsin from patients with congenital disorders of glycosylation type I have increased fucosylation and branching relative to normal controls. The elevated levels of monofucosylated biantennary glycans are probably due to increased alpha-(1-->6) fucosylation. The presence of bi- and trifucosylated triantennary and tetra-antennary glycans indicated that peripheral alpha-(1-->3), as well as core alpha-(1-->6), fucosylation is increased. Altered processing was observed on both the fully and underglycosylated glycoforms.
Similar articles
-
The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random.Glycobiology. 2003 Feb;13(2):73-85. doi: 10.1093/glycob/cwg026. Epub 2002 Dec 17. Glycobiology. 2003. PMID: 12626422
-
Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia).FEBS Lett. 2001 Apr 13;494(3):232-5. doi: 10.1016/s0014-5793(01)02349-3. FEBS Lett. 2001. PMID: 11311246
-
A procedure for the analysis of site-specific and structure-specific fucosylation in alpha-1-antitrypsin.Electrophoresis. 2016 Oct;37(20):2624-2632. doi: 10.1002/elps.201600176. Epub 2016 Sep 5. Electrophoresis. 2016. PMID: 27439567 Free PMC article.
-
Mass spectrometry for congenital disorders of glycosylation, CDG.J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 21;838(1):3-8. doi: 10.1016/j.jchromb.2006.02.028. Epub 2006 Mar 6. J Chromatogr B Analyt Technol Biomed Life Sci. 2006. PMID: 16517226 Review.
-
Identification of protein-bound carbohydrates by mass spectrometry.Proteomics. 2001 Feb;1(2):311-28. doi: 10.1002/1615-9861(200102)1:2<311::AID-PROT311>3.0.CO;2-J. Proteomics. 2001. PMID: 11680878 Review.
Cited by
-
Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!J Inherit Metab Dis. 2003;26(2-3):99-118. doi: 10.1023/a:1024431131208. J Inherit Metab Dis. 2003. PMID: 12889654
-
Nrf2 activation attenuates genetic endoplasmic reticulum stress induced by a mutation in the phosphomannomutase 2 gene in zebrafish.Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2758-2763. doi: 10.1073/pnas.1714056115. Epub 2018 Feb 22. Proc Natl Acad Sci U S A. 2018. PMID: 29472449 Free PMC article.
-
Glycan analysis by reversible reaction to hydrazide beads and mass spectrometry.Anal Chem. 2012 Mar 6;84(5):2232-8. doi: 10.1021/ac202769k. Epub 2012 Feb 10. Anal Chem. 2012. PMID: 22304307 Free PMC article.
-
Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci.Glycobiology. 2009 Dec;19(12):1554-62. doi: 10.1093/glycob/cwp136. Epub 2009 Sep 3. Glycobiology. 2009. PMID: 19729382 Free PMC article.
-
Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx.J Inherit Metab Dis. 2003;26(2-3):119-34. doi: 10.1023/a:1024476915278. J Inherit Metab Dis. 2003. PMID: 12889655 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical